Search
Generic filters
Search in excerpt

vaccine

First training cycle on vector-borne diseases in the Netherlands

Syva reaffirms its commitment to sheep veterinarians at Ovinnova 2025

Syvazul® BTV 3 receives EMA authorization for cattle

CVMP grants Positive opinion for Syvazul® BTV3 for Europe

ANEMBE 2025 Congress: A look back at the highlights of our symposium

Syvazul® BTV3 to receive emergency use authorization in France

Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium

Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).

Javier Sanz gave an interview to Animal’s Health

Syva acoge una mesa redonda sobre el desarrollo del Parque Tecnológico de León

Syva facilities host a round table on the development of León Technology Park

Syvac® EH Marker: the first and unique DIVA vaccine against EHD

The DGAV, authorized SYVAZUL BTV3, Syva’s vaccine against bluetongue serotype 3.

New tool for controlling erysipelas and PPV: Syvac® Ery Parvo